In memoriam: Professor Shigeto Yamawaki (January 15, 1954–June 8, 2026)—a visionary leader connecting Japan, Asia, and the world
Kazutaka Ikeda(Tokyo Metropolitan Institute of Medical Science), Go Okada(Hiroshima University), Gregers Wegener(Aarhus University), Hiroyuki Uchida(Keio University), Siegfried Kasper(Medical University of Vienna), Atsumi Nitta(University of Toyama), John H. Krystal(Yale University), Toshikazu Saito(Sapporo Medical University), Pierre Blier(University of Ottawa), Anthony Phillips(University of British Columbia), Joseph Zohar(Tel Aviv University), Hans-Jürgen Möller(Ludwig-Maximilians-Universität München), Gabriella Gobbi(McGill University)
Cited by 0
Related Papers
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
|JAMA Psychiatry|2019|911
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
|World Psychiatry|2023|751
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
|American Journal of Psychiatry|2021|707
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
|Proceedings of the National Academy of Sciences|2005|677